Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis

Condition:   Allergic Conjunctivitis Interventions:   Drug: Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo;   Drug: Ketotifen fumarate ophthalmic solution 0.035%;   Drug: Brimonidine tartrate ophthalmic solution 0.025%;   Drug: Vehicle ophthalmic solution Sponsor:   Bausch & Lomb Incorporated Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials